PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.51%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
-2.33%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-4.92%
Negative EBIT growth while 3141.T is at 32.47%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-5.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-5.25%
Negative net income growth while 3141.T stands at 2.70%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.25%
Negative EPS growth while 3141.T is at 2.71%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.25%
Negative diluted EPS growth while 3141.T is at 2.71%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 1.39%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.89%
10Y revenue/share CAGR under 50% of 3141.T's 83.17%. Michael Burry would suspect a lasting competitive disadvantage.
2.89%
5Y revenue/share CAGR under 50% of 3141.T's 83.17%. Michael Burry would suspect a significant competitive gap or product weakness.
-21.33%
Negative 3Y CAGR while 3141.T stands at 30.74%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
10Y OCF/share CAGR in line with 3141.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
100.00%
5Y OCF/share CAGR is similar to 3141.T's 100.00%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
100.00%
3Y OCF/share CAGR similar to 3141.T's 100.00%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
79.77%
Below 50% of 3141.T's 241.53%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
79.77%
Below 50% of 3141.T's 241.53%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-8.48%
Negative 3Y CAGR while 3141.T is 200.79%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
37.97%
Equity/share CAGR of 37.97% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
37.97%
Equity/share CAGR of 37.97% while 3141.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-7.15%
Negative 3Y equity/share growth while 3141.T is at 86.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.88%
Firm’s AR is declining while 3141.T shows 6.48%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.67%
Inventory shrinking or stable vs. 3141.T's 17.15%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.78%
Asset growth well under 50% of 3141.T's 10.71%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.84%
Under 50% of 3141.T's 25.28%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-13.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-1.33%
We cut SG&A while 3141.T invests at 33.46%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.